Literature DB >> 8344410

Haemonchus contortus: ivermectin-induced paralysis of the pharynx.

T G Geary1, S M Sims, E M Thomas, L Vanover, J P Davis, C A Winterrowd, R D Klein, N F Ho, D P Thompson.   

Abstract

How the avermectins cause the elimination of gastrointestinal nematodes from host animals has not yet been clearly identified. Using visual and radiometric parameters to measure oral ingestion in Haemonchus contortus, we showed that ivermectin (IVM) rapidly inhibited ingestion at concentrations > or = 10(-10) M. Motility, monitored quantitatively with an automated motility meter, was unaffected by IVM at concentrations < or = 10(-8) M, while ATP levels were unaffected at concentrations < or = 10(-6) M. Since motility and ATP levels, independent measures of short-term viability, are unaffected by concentrations of IVM that effectively block oral ingestion, the drug can be used as a chemical ligature. Although H. contortus was shown to be dependent upon an exogenous supply of glucose for survival in culture, IVM (10(-9) and 10(-7) M) altered neither the uptake of 3-O-[3H]methylglucose nor the metabolism of [13C]glucose by the parasite. These data suggest that H. contortus depends upon the transcuticular uptake of glucose in culture. If oral ingestion of other nutrients is essential for long-term survival in vivo, disruption of this process may represent the primary mechanism of IVM action.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8344410     DOI: 10.1006/expr.1993.1064

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  46 in total

1.  Ivermectin disrupts the function of the excretory-secretory apparatus in microfilariae of Brugia malayi.

Authors:  Yovany Moreno; Joseph F Nabhan; Jonathan Solomon; Charles D Mackenzie; Timothy G Geary
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-01       Impact factor: 11.205

Review 2.  Control of nematode parasites with agents acting on neuro-musculature systems: lessons for neuropeptide ligand discovery.

Authors:  Richard J Martin; Alan P Robertson
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

3.  avr-15 encodes a chloride channel subunit that mediates inhibitory glutamatergic neurotransmission and ivermectin sensitivity in Caenorhabditis elegans.

Authors:  J A Dent; M W Davis; L Avery
Journal:  EMBO J       Date:  1997-10-01       Impact factor: 11.598

4.  The role of Brugia malayi ATP-binding cassette (ABC) transporters in potentiating drug sensitivity.

Authors:  Jeffrey B Tompkins; Laurel E Stitt; Alana M Morrissette; Bernadette F Ardelli
Journal:  Parasitol Res       Date:  2011-04-15       Impact factor: 2.289

Review 5.  How do the macrocyclic lactones kill filarial nematode larvae?

Authors:  Adrian J Wolstenholme; Mary J Maclean; Ruby Coates; Ciaran J McCoy; Barbara J Reaves
Journal:  Invert Neurosci       Date:  2016-06-09

6.  A reappraisal of the relative sensitivity of nematode pharyngeal and somatic musculature to macrocyclic lactone drugs.

Authors:  Andrew C Kotze; Barney M Hines; Angela P Ruffell
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2011-11-10       Impact factor: 4.077

Review 7.  Ion channels and receptor as targets for the control of parasitic nematodes.

Authors:  Adrian J Wolstenholme
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2011-10-14       Impact factor: 4.077

8.  Cyclotide interactions with the nematode external surface.

Authors:  Michelle L Colgrave; Yen-Hua Huang; David J Craik; Andrew C Kotze
Journal:  Antimicrob Agents Chemother       Date:  2010-03-08       Impact factor: 5.191

9.  Actin isoforms in the parasitic nematode Haemonchus contortus.

Authors:  A Criado-Fornelio; A Jimenez-Gonzalez; F Rodriguez-Caabeiro
Journal:  Parasitol Res       Date:  1995       Impact factor: 2.289

10.  Purifying selection and demographic expansion affect sequence diversity of the ligand-binding domain of a glutamate-gated chloride channel gene of Haemonchus placei.

Authors:  Ted H M Mes
Journal:  J Mol Evol       Date:  2004-04       Impact factor: 2.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.